Plato BioPharma Revenue and Competitors
Estimated Revenue & Valuation
- Plato BioPharma's estimated annual revenue is currently $775k per year.
- Plato BioPharma's estimated revenue per employee is $155,000
Employee Data
- Plato BioPharma has 5 Employees.
- Plato BioPharma grew their employee count by -44% last year.
Plato BioPharma's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Study Director III | Reveal Email/Phone |
2 | Associate Scientist II | Reveal Email/Phone |
Plato BioPharma Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.4M | 35 | 483% | $25M | N/A |
#2 | $2M | 13 | 18% | N/A | N/A |
#3 | $3.4M | 22 | 10% | N/A | N/A |
#4 | $68M | 439 | -3% | N/A | N/A |
#5 | $2M | 13 | 30% | N/A | N/A |
#6 | $4M | 26 | 8% | N/A | N/A |
#7 | $2.7M | 35 | -10% | $23.2M | N/A |
#8 | $5.3M | 34 | 70% | N/A | N/A |
#9 | $1.7M | 11 | -8% | N/A | N/A |
#10 | $3.1M | 20 | -17% | N/A | N/A |
What Is Plato BioPharma?
Plato BioPharma, Inc. (PBI) offers an integrative approach to pre-clinical drug discovery in the cardiovascular, renal, pulmonary, and hepatic therapeutic areas. PBI's pre-clinical pharmacology platform begins with intricate in vivo models of disease followed by a systematic analysis of biomarkers, biochemicals and histology. This unified process provides our clients with constellations of data that aid to navigate the maze of drug discovery and development.
keywords:N/A
N/A
Total Funding
5
Number of Employees
$775k
Revenue (est)
-44%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Westminster
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.7M | 5 | 0% | N/A |
#2 | $0.4M | 5 | -37% | N/A |
#3 | $0.5M | 5 | 0% | N/A |
#4 | $0.4M | 5 | -17% | N/A |
#5 | $0.8M | 5 | 25% | N/A |